# Magenta Elevate™ First-in-Human Clinical Study in High-Risk PCI Patients

> **NCT06099548** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Magenta Medical Ltd.** · enrollment: 20 (estimated)

## Conditions studied

- High-Risk Percutaneous Coronary Intervention

## Interventions

- **DEVICE:** The Elevate™ System

## Key facts

- **NCT ID:** NCT06099548
- **Lead sponsor:** Magenta Medical Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-12-17
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06099548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06099548, "Magenta Elevate™ First-in-Human Clinical Study in High-Risk PCI Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06099548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*